4D Lifetec secures CHF 23.3 Mio in a share and investment deal with Xlife Sciences opening new horizons in using AI and digital health in early cancer detection.
20.10.2023
It is with great pleasure that we announce that our portfolio company, 4D Lifetec AG, has achieved a groundbreaking success. In close partnership with Xlife Sciences AG, 4D Lifetec not only receives a valuable financial investment of CHF 23.3 million, but also advanced AI technology. This innovation will pave the way for revolutionary early cancer detection and expansion of presence in the US. Read more about this milestone in the latest Genomweb post.
Learn more…